Literature DB >> 2311304

The effect of cyclosporin A on the interstitial mononuclear cell infiltration and the induction of Heymann's nephritis.

C Grönhagen-Riska1, E von Willebrand, T Tikkanen, E Honkanen, A Miettinen, H Holthöfer, T Törnroth.   

Abstract

Heymann's nephritis was induced with brush-border (BB) antigen. Interstitial mononuclear cell infiltration was studied with cytological examinations of fine-needle aspiration biopsies (FNAB), and with immunoperoxidase stains of frozen sections with monoclonal antisera. The effect of cyclosporin A (CyA), 20 mg/kg when administered intraperitoneally for 8 days in association with both initial immunization, and with the booster 4 weeks later, on the interstitial leukocyte infiltration and on the development of membranous glomerulonephritis (MGN) and proteinuria were investigated. Another group of rats was immunized, but not given CyA. Experimental animals were killed in groups 3, 6 and 20 weeks after initial immunization. CyA inhibited significantly the initial interstitial lymphocyte and blast cell response at 3 weeks (FNAB), but did not inhibit the secondary response after the booster. The anti-BB titre reacted in a similar fashion. Immunoperoxidase stains indicated a clearly suppressed T suppressor/cytolytic (T s/c) cell response. Glomerular basement membrane (GBM) deposits of IgG developed more slowly and were more scarce in the CyA-treated rats, when compared with the untreated group. Only one out of 15 CyA treated rats developed C3 deposits in the GBM during the course of the study, and none developed proteinuria, when most untreated rats (10/17) had C3 deposits and were nephrotic at 20 weeks. Thus, CyA depressed the initial interstitial cellular response after immunization with BB antigen, and also inhibited the development of antibody response, C3 deposits and proteinuria of Heymann nephritis. These effects of CyA may be contributed to an inhibited amplification of the autoimmune response associated with interstitial damage and continuous release of autoantigen.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2311304      PMCID: PMC1534753          DOI: 10.1111/j.1365-2249.1990.tb05189.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  16 in total

1.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

2.  Induction, characterization, and cell transfer of autoimmune tubulointerstitial nephritis.

Authors:  K M Bannister; T R Ulich; C B Wilson
Journal:  Kidney Int       Date:  1987-11       Impact factor: 10.612

3.  Cyclosporine A induced remission of relapsing nephrotic syndrome in children.

Authors:  A T Tejani; K Butt; H Trachtman; M Suthanthiran; C J Rosenthal; M R Khawar
Journal:  Kidney Int       Date:  1988-03       Impact factor: 10.612

4.  Practical guidelines for fine needle aspiration biopsy of human renal allografts.

Authors:  P Häyry; E von Willebrand
Journal:  Ann Clin Res       Date:  1981

5.  Fine-needle aspiration cytology of human renal transplants.

Authors:  E von Willebrand
Journal:  Clin Immunol Immunopathol       Date:  1980-11

6.  Effects of cyclosporin A on the development of immune-mediated interstitial nephritis.

Authors:  W Shih; W H Hines; E G Neilson
Journal:  Kidney Int       Date:  1988-06       Impact factor: 10.612

7.  Stimulation of circulating autoantibody levels in the rat with established progressive passive Heymann nephritis.

Authors:  A Z Barabas; J Cornish; R Lannigan
Journal:  Clin Exp Immunol       Date:  1986-07       Impact factor: 4.330

8.  Modulation of experimental autoimmune uveitis with cyclosporin A.

Authors:  R B Nussenblatt; M M Rodrigues; M C Salinas-Carmona; I Gery; S Cevario; W Wacker
Journal:  Arch Ophthalmol       Date:  1982-07

9.  Effect of cyclosporine on in situ immune complex glomerulonephritis.

Authors:  F Thaiss; M J Mihatsch; S Batsford; A Vogt; P Schollmeyer
Journal:  Clin Nephrol       Date:  1986       Impact factor: 0.975

10.  Interstitial mononuclear cell infiltration in Heymann nephritis.

Authors:  C Grönhagen-Riska; E Honkanen; E von Willebrand; I Tikkanen; A Miettinen; H Holthöfer; T Törnroth
Journal:  Clin Exp Immunol       Date:  1987-11       Impact factor: 4.330

View more
  5 in total

1.  Cyclosporin A in the prevention and treatment of experimental autoimmune glomerulonephritis in the brown Norway rat.

Authors:  J Reynolds; S J Cashman; D J Evans; C D Pusey
Journal:  Clin Exp Immunol       Date:  1991-07       Impact factor: 4.330

Review 2.  Inflammation and glomerular injury.

Authors:  A Benigni; G Remuzzi
Journal:  Springer Semin Immunopathol       Date:  1994

Review 3.  Cyclosporin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders.

Authors:  Diana Faulds; Karen L Goa; Paul Benfield
Journal:  Drugs       Date:  1993-06       Impact factor: 9.546

4.  Partial prevention of active Heymann nephritis by 1 alpha, 25 dihydroxyvitamin D3.

Authors:  D D Branisteanu; P Leenaerts; B van Damme; R Bouillon
Journal:  Clin Exp Immunol       Date:  1993-12       Impact factor: 4.330

Review 5.  Tubulointerstitial nephritis.

Authors:  C L Jones; A A Eddy
Journal:  Pediatr Nephrol       Date:  1992-11       Impact factor: 3.714

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.